Hand–foot syndrome (HFS), also known as palmar–plantar erythrodysesthesia syndrome, is a cutaneous adverse event associated with cytotoxic agents (CTx) and BRAF inhibitors. Here, BRAF is linked to Hand-foot syndrome.